tICAM-1-453 (Bayer)

N/A

Report date: 2022/02/18 14:55:15

Base Information

Drug NametICAM-1-453 (Bayer)

Drug Alias NametICAM-1-453

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionIntercellular adhesion molecule-1 inhibitors

TargetsIntercellular adhesion molecule-1

Therapy Area/IndicationsRhinovirus infection

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBayer AG

Active IndicationsN/A

Inactive IndicationsRhinovirus infection

ATC CodeN/A